Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Singh, Ilina ^a   Bard, Imre ^b   Jackson, Jonathan ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; ALCOHOL; AMPHETAMINE PLUS DEXAMPHETAMINE; ANALGESIC AGENT; ATOMOXETINE; CAFFEINE; CANNABIS; COCAINE; DIAMORPHINE; DONEPEZIL; EPHEDRINE; KETAMINE; LYSERGIDE; METHAMPHETAMINE; METHYLPHENIDATE; MODAFINIL; PIRACETAM; TRANQUILIZER; VITAMIN; AMPHETAMINE DERIVATIVE; BENZHYDRYL DERIVATIVE; NOOTROPIC AGENT; WAKEFULNESS PROMOTING AGENT;

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ATTENTION DEFICIT DISORDER; ATTITUDE; BRITISH CITIZEN; CANNABIS USE; CONTROLLED STUDY; DRUG ABUSE; ENERGY DRINK; ETHICS; FEMALE; HUMAN; IRELAND; MALE; PHARMACOLOGICAL COGNITIVE ENHANCEMENT; PREDICTION; PREVALENCE; REVIEW; TOBACCO; UNITED KINGDOM; UNIVERSITY STUDENT; SEX DIFFERENCE; STUDENT;

CANNABIS;

ADOLESCENT; ADULT; AMPHETAMINES; BENZHYDRYL COMPOUNDS; FEMALE; GREAT BRITAIN; HUMANS; IRELAND; MALE; METHYLPHENIDATE; NOOTROPIC AGENTS; SEX FACTORS; STUDENTS; WAKEFULNESS-PROMOTING AGENTS;

EID: 84910092855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105969     Document Type: Review

References (34)

1. Hildt E (2013) Cognitive enhancement - A critical look at the current debate. In E Hildt, AG Franke, eds. Cognitive enhancement: An interdisciplinary perspective. London: Springer 1-14.
2. AAP (2013) Stress of study leads some to try 'academic doping', The Australian, 20 August. http://www.theaustralian.com.au/higher-education/stress-of-studyleads-some-to-try-academic-doping/story-e6frgcjx-1226699737256. Accessed 23 February 2014.
3. Paton G (2013) Universities warned of 'explosion' in use of smart drugs, The Telegraph 28 September http://www.telegraph.co.uk/education/university education/10340244/Universities-warned-of-explosion-in-use-of-smart-drugs.html. Accessed 20 February, 2014.
4. Sky News (2013) 'Smart Drug' Modafinil Risks Student Health, 28 September. http://news.sky.com/story/1147488/smart-drug-modafinil-risks-student-health Accessed 20 February, 2014.
5. Pustovrh T, Mali F (2013) Exploring some challenges of the pharmaceutical cognitive enhancement discourse: Users and policy recommendations. Neuroethics: 1-22.
6. Presidents Council on Bioethics (2003) Beyond therapy: Biotechnology and the pursuit of happiness. New York: Harper Collins.
7. Parliamentary Office of Science and Technology (POST) (2007) Better brains. No. 285. Parliamentary Office copyright www.parliament.uk/parliamentary-offices/post.cfm Accessed 10 February, 2014.
8. Comitato Nazionale per la Bioetica (13 March, 2013) Neuroscience and pharmacological cognitive enhancement: Bioethical aspects http://www.governo. it/bioetica/eng/opinions.html Accessed 23 February, 2014.
9. Smith ME, Farah MJ (2011) Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 137(5):717.
10. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, et al. (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1
11. DeSantis A, Noar SM, Webb E (2010) Speeding through the frat house: A qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education 40(2):157-171
12. Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, et al. (2011) Nonmedical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry 44(02):60-66.
13. Eickenhorst P, Vitzthum K, Klapp BF, Groneberg D, Mache S (2012) Neuroenhancement among German university students: Motives, expectations, and relationship with psychoactive lifestyle drugs. Journal of Psychoactive Drugs, 44(5):418-427.
14. Singh I, Filipe AM, Bard I, Bergey M, Baker L (2013) Globalization and cognitive enhancement: emerging social and ethical challenges for ADHD clinicians. Curr Psychiatry Rep 15(9):385-9.
15. Maier LJ, Liechti ME, Herzig F, Schaub MP (2013) To dope or not to dope: Neuroenhancement with prescription drugs and drugs of abuse among Swiss university students. PLoS ONE 8(11):e77967. doi: 10.1371/journal.pone.0077967
16. Ott R, Biller-Andorno N (2014) Neuroenhancement among Swiss students - A comparison of users and non-users. Pharmacopsychiatry 47(1):22-8.
17. Castaldi S, Gelatti U, Orizio G, Hartung U, Moreno-Londono AM, et al. (2012) Use of cognitive enhancement medication among northern Italian university students. Journal of Addiction Medicine 6(2):112-117.
18. Humle T, Friislund M (2010) 'Study drugs' vinder frem på universiteter. Information. http://www.information. dk/236139. Accessed 2014 February 23.
19. Holloway K, Bennett T (2012) Prescription drug misuse among university staff and students: A survey of motives, nature and extent. Drugs: education, prevention and policy. 19(2):137-144.
20. Ragan I, Bard I, Singh I (2012) What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology 64:588-95.
21. Lennard N (2009) One in ten takes drugs to study. Varsity Student Newspaper. March 6 http://www.varsity.co.uk/news/1307. Accessed 2014 February 20.
22. Partridge B (2013) A bubble of enthusiasm: How prevalent is the use of prescription stimulants for cognitive enhancement? In E. Hildt, AG. Frank (eds) Cognitive enhancement: An interdisciplinary perspective. Springer Netherlands: 39-47.
23. DeSantis AD, Webb E, Noar S (2008) Illicit use of prescription ADHD medications among college students: a multi-methodological approach. Journal of American College Health 57(3):315-323.
24. Workman TA, Eells G (2010) Assessing the Risks and Issues: Prescription Drug Abuse on Campus http://www.stetson.edu/law/conferences/highered/archive/media/higher-ed-archives-2010/assessing-the-risks-and-issues.pdf. Accessed 2014 February 23.
25. DeSantis AD, Hane AC (2010) "Adderall is definitely not a drug": Justifications for the illegal use of ADHD stimulants. Substance Use & Misuse 45(1-2):31-46.
26. Franke AG, Lieb K, Hildt E (2012) What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. PLOS One. DOI: 10.1371/journal.pone.0040047
27. Scheske C, Schnall S (2012) The ethics of "smart drugs": Moral judgments about healthy people's use of cognitive-enhancing drugs. Basic and Applied Social Psychology 34(6):508-515.
28. Hansard HC (2013) Deb 4, cc1072W-1073W.
29. Brant R (1990) Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics, 46:1171-1178.
30. EMCDDA (2002) Handbook for surveys on drug use among the general population. http://www.emcdda.europa.eu/html.cfm/index58052EN.html. Accessed 2014 Jan 26.
31. Peterkin AL, Crone CC, Sheridan MJ, Wise TN (2010) Cognitive performance enhancement: Misuse of self-treatment. J Atten Disord. doi: 10.1177/1089054710365980
32. Ly C, Gehricke JG (2013) Marijuana use is associated with inattention in men and sleep quality in women with Attention-Deficit/Hyperactivity Disorder: A preliminary study. Psychiatry Research 2010:1310-1312.
33. Bergström LS, Lynöe N (2008) Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. Scandinavian Journal of Public Health 36(5):532-537.
34. Reips UD (2002) Standards for Internet-based experimenting. Experimental Psychology 49(4):243-56.